PRMT5 INHIBITORS

The invention relates to substituted nucleoside analogues of formula (I), pharmaceutically acceptable salts thereof and pharmaceutical compositions for treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme. The invention also relates to methods of treating dis...

Full description

Saved in:
Bibliographic Details
Main Authors NAIR, Prathap Sreedharan, PALLE, Venkata P, GUDADE, Ganesh Bhausaheb, TRYAMBAKE, Mahadeo Bhaskar, KAMBOJ, Rajender Kumar, LAGAD, Dipak Raychand, SINDKHEDKAR, Milind Dattatraya, KULKARNI, Chaitanya Prabhakar, PAWAR, Chetan Sanjay
Format Patent
LanguageEnglish
Published 30.11.2022
Online AccessGet full text

Cover

More Information
Summary:The invention relates to substituted nucleoside analogues of formula (I), pharmaceutically acceptable salts thereof and pharmaceutical compositions for treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme. The invention also relates to methods of treating diseases, disorders or conditions associated with the overexpression of PRMT5 enzyme.
Bibliography:Application Number: ZA20210009573